Stocks and Investing Stocks and Investing
Fri, July 8, 2022
Thu, July 7, 2022
Wed, July 6, 2022
Tue, July 5, 2022

Brian Skorney Maintained (VRTX) at Hold and Held Target at $250 on, Jul 5th, 2022


Published on 2024-10-27 21:45:03 - WOPRAI, Brian Skorney
  Print publication without navigation


Brian Skorney of Baird, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $250 on, Jul 5th, 2022.

Brian has made no other calls on VRTX in the last 4 months.



There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 5 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $267 on, Sunday, June 12th, 2022
  • David Risinger of "SVB Leerink" Initiated at Hold and Held Target at $265 on, Monday, May 23rd, 2022
  • Do Kim of "Piper Sandler" Maintained at Hold with Decreased Target to $242 on, Friday, May 6th, 2022
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $240 on, Thursday, May 5th, 2022
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $250 on, Tuesday, May 3rd, 2022


These are the ratings of the 8 analyists that currently disagree with Brian


  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $280 on, Monday, June 13th, 2022
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $310 on, Monday, June 13th, 2022
  • Jason McCarthy of "Maxim Group" Upgraded from Hold to Strong Buy and Held Target at $325 on, Wednesday, June 1st, 2022
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $278 on, Tuesday, May 24th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $305 on, Friday, May 6th, 2022
  • Gena Wang of "Barclays" Maintained at Buy and Held Target at $291 on, Thursday, May 5th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $322 on, Wednesday, April 27th, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $350 on, Monday, April 4th, 2022